[The effect of DOPA on catecholamine metabolism in spinal pain syndrome].
D000311:Adrenal Glands / Q000737:chemistry; D000818:Animals; D001923:Brain Chemistry; D002395:Catecholamines / Q000097:blood / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D004837:Epinephrine / Q000032:analysis / Q000378:metabolism; D005470:Fluorometry; D007031:Hypothalamus / Q000737:chemistry; D007274:Injections, Intraperitoneal; D008297:Male; D009206:Myocardium / Q000737:chemistry; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism; D009647:Normetanephrine / Q000032:analysis; D010146:Pain / Q000139:chemically induced / Q000378:metabolism; D051381:Rats; D013122:Spinal Diseases / Q000139:chemically induced / Q000378:metabolism*; D013577:Syndrome; D013744:Tetanus Toxin / Q000494:pharmacology; D013997:Time Factors
D002395:Catecholamines; D013744:Tetanus Toxin; D009647:Normetanephrine; D004295:Dihydroxyphenylalanine; D009638:Norepinephrine; D004837:Epinephrine
Vliianie DOFA na obmen katekholaminov pri spinal'nom bolevom sindrome.